Stifel Nicolaus reaffirmed their buy rating on shares of HCP (NYSE:HCP) in a research note published on Wednesday morning. Stifel Nicolaus currently has a $27.00 price objective on the real estate investment trust’s stock, down from their previous price objective of $29.00.
HCP has been the topic of a number of other research reports. KeyCorp reissued a hold rating on shares of HCP in a research note on Tuesday, October 17th. BMO Capital Markets reissued a hold rating and issued a $28.00 price target on shares of HCP in a research note on Wednesday, October 18th. Mizuho raised shares of HCP from a neutral rating to a buy rating and set a $32.00 price target on the stock in a research note on Thursday, November 2nd. Zacks Investment Research raised shares of HCP from a sell rating to a hold rating in a research note on Thursday, November 9th. Finally, Morgan Stanley reissued an equal weight rating and issued a $29.00 price target on shares of HCP in a research note on Thursday, December 14th. Four equities research analysts have rated the stock with a sell rating, ten have given a hold rating and four have assigned a buy rating to the stock. HCP presently has an average rating of Hold and a consensus price target of $29.23.
Shares of HCP (NYSE HCP) traded up $0.01 during midday trading on Wednesday, hitting $21.78. 2,532,375 shares of the stock were exchanged, compared to its average volume of 4,585,546. The firm has a market cap of $10,703.31, a PE ratio of 25.27, a price-to-earnings-growth ratio of 4.16 and a beta of 0.27. HCP has a twelve month low of $21.64 and a twelve month high of $33.67. The company has a quick ratio of 0.61, a current ratio of 0.61 and a debt-to-equity ratio of 1.17.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 2nd. Shareholders of record on Thursday, February 15th will be issued a $0.37 dividend. The ex-dividend date is Wednesday, February 14th. This represents a $1.48 dividend on an annualized basis and a yield of 6.80%. HCP’s payout ratio is currently 172.09%.
Hedge funds have recently made changes to their positions in the business. Advisory Services Network LLC lifted its holdings in HCP by 4.1% in the 2nd quarter. Advisory Services Network LLC now owns 3,782 shares of the real estate investment trust’s stock valued at $121,000 after purchasing an additional 150 shares in the last quarter. Vestpro Financial Partners Inc. dba CPF Texas purchased a new position in shares of HCP during the 4th quarter worth $103,000. Fieldpoint Private Securities LLC purchased a new position in shares of HCP during the 3rd quarter worth $147,000. Penserra Capital Management LLC purchased a new position in shares of HCP during the 3rd quarter worth $163,000. Finally, Cetera Investment Advisers purchased a new position in shares of HCP during the 2nd quarter worth $208,000. Institutional investors own 90.23% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This story was originally published by Week Herald and is owned by of Week Herald. If you are viewing this story on another website, it was illegally copied and republished in violation of United States & international trademark & copyright law. The original version of this story can be viewed at https://weekherald.com/2018/02/15/hcp-hcp-receives-buy-rating-from-stifel-nicolaus.html.
HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.
Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.